KnowraMetoclopramideLinked fromLinked fromThe 12 pages that link to Metoclopramide, each with the reason it gives.All 12Broader topic 3Related 5Compared with 4ProlactinCompared with: By blocking dopamine action, it can raise prolactin as an unintended drug effect.Neuroleptic malignant syndromeRelated: This non-psychiatric dopamine-blocking drug can also precipitate the syndrome.Dopamine D2 receptorRelated: Its D2 blockade treats nausea but can also cause movement-related adverse effects.OndansetronCompared with: It offers a different receptor profile and can promote gastric emptying.Tardive dyskinesiaRelated: Long-term exposure can cause tardive dyskinesia, showing that risk is not limited to psychiatric drugs.AntiemeticBroader topic: Its combined dopamine-blocking and gut-motility actions distinguish it from ondansetron.Extrapyramidal symptomsRelated: Long-term exposure can cause tardive dyskinesia, showing that risk extends beyond psychiatric drugs.VomitingBroader topic: It can reduce vomiting by acting on dopamine pathways and improving gastric emptying.AkathisiaRelated: This anti-nausea drug can cause akathisia as well as other movement-related adverse effects.Chemoreceptor trigger zoneBroader topic: Its D2 blockade can reduce trigger-zone signaling, while its gut effects address additional nausea pathways.PromethazineCompared with: It offers an alternative antiemetic mechanism, with distinct movement-related risks.DomperidoneCompared with: Unlike domperidone, it more often causes central neurological effects such as movement disorders.